baber/WOPTO huggingface dataset:
Patent AU-2019315974-A1 (AU)
Title: Power control method and device, terminal, and storage medium
Inventor: ZHANG YI
IPC: H04W52/08
Filed: 2019-07-30
Abstract: Disclosed are a power control method and device, a terminal, and a storage medium. The method comprises: determining a reference point corresponding to the closed-loop power control parameter of a PUSCH transmission unit i; determining a power adjustment amount corresponding to the closed-loop power control parameter of the transmission unit i; determining the closed-loop power control parameter of the transmission unit i according to the reference point and the power adjustment amount; and determining the transmit power of uplink data to be transmitted at the transmission unit i according to the closed-loop power control parameter of the transmission unit i.
Patent AU-2019325814-A1 (AU)
Title: Surgical smoke and gases venting cannula attachment
Inventor: PEGMAN BENJAMIN ELLIOT HARDINGE
IPC: A61M13/00
Filed: 2019-08-21
Abstract: Various venting attachments or leak devices can be removably or permanently coupled to a surgical cannula to allow a user to vent gases, in particular smoke, from a surgical cavity. The venting attachment can be configured to vent the smoke at a predetermined rate and filter out the smoke prior to venting to atmosphere. The substantially constant venting flow rate can promote clearing of the smoke in the surgical cavity while helping to maintain a substantially constant pressure, and thus stability, in the surgical cavity.
Patent AU-2019330998-A1 (AU)
Title: Sample well fabrication techniques and structures for integrated sensor devices
Inventor: SCHMID GERARD
IPC: B01L3/00
Filed: 2019-08-29
Abstract: Methods of forming an integrated device, and in particular forming one or more sample wells in an integrated device, are described. The methods may involve forming a metal stack over a cladding layer, forming an aperture in the metal stack, forming first spacer material within the aperture, and forming a sample well by removing some of the cladding layer to extend a depth of the aperture into the cladding layer. In the resulting sample well, at least one portion of the first spacer material is in contact with at least one layer of the metal stack.
Patent AU-2019332918-A1 (AU)
Title: Cooler for beverage and food products
Inventor: JAIN SANDEEP
IPC: F25D25/02
Filed: 2019-08-27
Abstract: Coolers for dispensing products, such as beverages, having multiple doors for accessing a single product compartment. A cooler may include a housing defining a product compartment; a top door coupled to a top surface of the housing at a hinge, the top door comprising a curved transparent panel; a vertical door coupled to a vertical front surface of the housing; a collapsible shelf disposed in the product compartment that is configured to move between an extended position and a retracted position; and a lower shelf disposed below the collapsible shelf in the product compartment. A product disposed on the collapsible shelf may be accessible through the top door when the collapsible shelf is in the extended position and a product disposed on the lower shelf may be accessible through the top door when the collapsible shelf is in the retracted position.
Patent AU-2019346466-A1 (AU)
Title: DLL3 binding proteins and methods of use
Inventor: WESCHE HOLGER
IPC: C07K16/30
Filed: 2019-09-25
Abstract: Provided herein are DLL3 binding proteins and DLL3 targeting multispecific proteins (e.g., DLL3 targeting trispecific protein) comprising a domain binding to CD3, a half-life extension domain, and a domain binding to DLL3 (such as a DLL3 binding protein as provided herein). Also provided are pharmaceutical compositions thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such DLL3 binding proteins, DLL3 targeting trispecific proteins. Also disclosed are methods of using the disclosed DLL3 binding proteins, DLL3 targeting trispecific proteins in the prevention, and/or treatment diseases, conditions and disorders.
Patent AU-2019355546-A1 (AU)
Title: System and method for monitoring the status of one or more components of an electrical machine
Inventor: CUTSFORTH ROBERT S
IPC: H01R39/58
Filed: 2019-10-03
Abstract: A system for monitoring the wear state of a carbon brush of a brush holder assembly in which the length of the carbon brush is diminished from an initial length as an end of the carbon brush wears away during use. The system includes a wear state monitor, including a sensor, coupled to the carbon brush. The wear state monitor is configured to rotate as the length of the carbon brush diminishes. The sensor is configured to measure an angular displacement of the wear state monitor as the wear state monitor rotates. The measured angular displacement of the wear state monitor correlates to an amount of diminution in the length of the carbon brush.
Patent AU-2019362312-A1 (AU)
Title: Products, uses and methods
Inventor: MARTINEZ VIRGINIA
IPC: C12N15/63
Filed: 2019-10-14
Abstract: The invention relates to the production and use of Cas-encoding sequences and vectors comprising these. Aspects of the invention provide products, vectors, delivery vehicles, uses and methods for producing Cas-encoding sequences in bacterial or archaeal cells.
Patent AU-2019363368-A1 (AU)
Title: Use of anti-FAM19A5 antibodies
Inventor: KIM BONGCHEOL
IPC: C07K16/24
Filed: 2019-10-15
Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat a retinopathy (e.g., diabetic retinopathy) and/or maculopathy (e.g., age-related macular degeneration) in a subject in need thereof.
Patent AU-2019379287-A1 (AU)
Title: Terminal deoxynucleotidyl transferase variants and uses thereof
Inventor: CHAMPION ELISE
IPC: C12N9/12
Filed: 2019-11-13
Abstract: The present invention is directed to terminal deoxynucleotidyltransferase (TdT) variants that (i) comprise an amino acid sequence that is at least a specified percent identical to an indicated SEQ ID NOs and have at least one substitution at Q455 or at least Q455 plus at least one further substitution at G186, S248, T331, Q390, K394 or H466 (where positions are with respect to SEQ ID NO 1 and functionally equivalent positions in indicated SEQ ID NOs), (ii) are capable of template-free extension of a polynucleotide, and (iii) exhibit enhanced stability or enhanced efficiency in incorporating 3'-0-blocked nucleoside triphosphates into a polynucleotide. The invention is also directed to the use of these TdT variants for synthesizing polynucleotides of any predetermined sequence.
Patent AU-2019382881-A1 (AU)
Title: Formulation of contrast media and process of preparation thereof
Inventor: HOLZSCHUH STEPHAN
IPC: A61K49/08
Filed: 2019-11-21
Abstract: The present disclosure relates to a liquid pharmaceutical formulation comprising a DOSA-derived tetra-chelate of formula (I), in which M is an ion of a paramagnetic metal, preferably a Gd
Patent AU-2019435416-A1 (AU)
Title: Fruit and whey compositions
Inventor: BELLET MOSNIER ELODIE
IPC: A23L33/19
Filed: 2019-03-15
Abstract: Fruit preparations comprising whey and having a desirable viscosity and texture are described. Fruit preparations described include about 3% to 16% whey protein by weight and at least 30% fruit ingredient by weight. Methods of making fruit preparations comprising whey are also described.
Patent AU-2019474268-A1 (AU)
Title: Structure for supporting marine installations and procedure for the execution thereof
Inventor: COBIÁN BABÉ IGNACIO
IPC: E02D27/42
Filed: 2019-11-12
Abstract: A structure (2) for supporting a wind turbine tower (1) having a housing (7) for the fitting therein of the foot of the tower (1), a principal axis (1') being defined on the platform (2) and coinciding with the principal axis of the tower (1), and comprising a constant-section body with a number of internal walls (8) and intermediate walls (10) joined by internal radial ribbing (11) perpendicular to the internal wall (8) whose plane passes through the principal axis (1'), in such a way that at the intermediate wall (10) a number of first interconnection nodes (12) are defined between the intermediate wall (10) and the radial ribbing (11), the intermediate wall (10) and an external wall (9) being linked by reticular ribbing (14 and 15). This structure provides an optimal transmission of forces. The invention likewise relates to procedures for the manufacture, assembly and installation of the structure.
Patent WO-2021163748-A1 (WO)
Title: Bulk material conveyor
Inventor: COONEY GRAEME
IPC: B65G41/00
Filed: 2020-05-28
Abstract: A road portable bulk material conveyor capable of being towed by a prime mover, or the like, having a hopper to receive bulk materials, a hopper frame to support the hopper, a conveyor having a material input end and a material output end, a chassis having a wheel assembly supporting at least a portion of the conveyor, and a vehicle attachment assembly to connect the bulk material conveyor to the towing vehicle. The bulk material conveyor has a transport position in which the hopper, hopper frame, and conveyor are supported by the wheel assembly of the chassis and the vehicle attachment assembly for movement. Once in position, the bulk material conveyor can be deployed to a material handling position in which the hopper is supported by the hopper frame on a ground surface, and the conveyor is at least partially supported by the chassis such that the conveyor extends from its input end underneath the hopper to its output end distal from the input end.
Patent WO-2021035308-A1 (WO)
Inventor: SARGEANT TIMOTHY
IPC: G01N33/53
Filed: 2020-08-28
Abstract: The present disclosure relates to relates to methods and products for assessing lysosomal system flux. In addition, the present disclosure also provides systems for assessing lysosomal system flux, and methods of identifying markers indicative of lysosomal system flux. In certain embodiments, the present disclosure provides a method of assessing lysosomal system flux in a subject. The method comprises determining the level of a lysosomal system marker in a sample of whole blood from the subject, the level of the lysosomal system marker being determined based on the level of the marker following treatment of the whole blood with an inhibitor of lysosomal system function.
Patent WO-2021042161-A1 (WO)
Inventor: VEEDU RAKESH NADUVILE
IPC: C12N15/113
Filed: 2020-09-02
Abstract: L'invention concerne un oligomère antisens isolé ou purifié pour modifier l'épissage de pré-ARNm dans le transcrit de gène LIN28B ou une partie de celui-ci qui a une structure de squelette modifiée et des séquences ayant au moins 95 % d'identité de séquence avec l'oligomère antisens isolé ou purifié qui a une structure de squelette modifiée pour modifier l'épissage de pré-ARNm, et/ou induire la RNase H et/ou un blocage translationnel dans le transcrit du gène LIN28B ou une partie de celui-ci.
Patent AU-2020202031-A1 (AU)
Title: Apparatus and methods for regulating cryogenic treatment
Inventor: BURNETT DANIEL R
IPC: A61B18/02
Filed: 2020-03-20
Abstract: Apparatus and methods for regulating cryogenic treatments are disclosed which comprise devices and methods for delivering controlled treatment of a cryoablative agent. In one variation, such devices may generally comprise an elongate probe having a distal tip and a flexible length, at least one infusion lumen positioned through or along the elongate probe, wherein the infusion lumen defines one or more openings along its length, and a liner expandably enclosing the probe. An inflow reservoir or canister valve may be fluidly coupled with a reservoir or canister containing the cryoablative agent and a modulation control unit may also be fluidly coupled with the inflow reservoir or canister valve and in fluid communication with the at least one infusion lumen. Additionally, a warming element may also be thermally coupled with the reservoir or canister. 96- 196 -190 1 -92
Patent AU-2020217715-A1 (AU)
Title: Combination gene targets for improved immunotherapy
Inventor: BENSON MICAH
IPC: C12N15/90
Filed: 2020-02-04
Abstract: The present disclosure provides methods and compositions related to the modification of immune effector cells to increase therapeutic efficacy. In some embodiments, immune effector cells modified to reduce expression of one or more endogenous target genes, or to reduce one or more functions of an endogenous protein to enhance effector functions of the immune cells are provided. In some embodiments, immune effector cells further modified by introduction of transgenes conferring antigen specificity, such as exogenous T cell receptors (TCRs) or chimeric antigen receptors (CARs) are provided. Methods of treating a cell proliferative disorder, such as a cancer, using the modified immune effector cells described herein are also provided.
Patent AU-2020220194-A1 (AU)
Title: Mono-,di- or polysaccharide used as metal inhibitor in the preparation of 68Ga-chelate-functionalized targeting agent
Inventor: WOUTERS LUDOVIC
IPC: A61K103/00
Filed: 2020-08-21
Abstract: The present invention relates the use of metal inhibitor in radiolabelling reactions using 
radioactive metals.  
1003146704
Patent AU-2020229314-A1 (AU)
Title: Intratympanic injector devices and needles for delivery of drugs and methods of use
Inventor: SACHERMAN KEVIN W
IPC: A61B1/227
Filed: 2020-02-24
Abstract: A system for delivering one or more therapeutics to a region of the ear, the region being internal to a tympanic membrane. The system includes a canal guide configured to be inserted within and fittingly engaged with walls of the ear canal and needle assembly having a flexible shaft sized to extend through the canal guide. The canal guide provides alignment of the needle assembly within the ear canal relative to the tympanic membrane. The canal guide includes a viewing lumen extending between a proximal end to a distal-most end of the canal guide and is sized to remain external to the tympanic membrane. The canal guide includes a guide lumen extending to a distal opening near the distal-most end of the canal guide. The guide lumen curves from a first axis to a second axis. Related devices, systems, and methods are provided.
Patent AU-2020230406-A1 (AU)
Title: Biodegradable container, method of forming and forming apparatus
Inventor: DZHALAZOV MLADEN
IPC: A21D13/33
Filed: 2020-03-04
Abstract: There is disclosed a method of forming a biodegradable container, such as a cup, comprising a plurality of successive press forming operations, each press forming operation comprising relative movement between an outer die 202 and an inner punch 204 from an open configuration to a forming configuration to shape a dough 400 as it expands. There is also disclosed a corresponding forming apparatus and container.
Patent AU-2020241559-A1 (AU)
Title: Technologies useful for oligonucleotide preparation
Inventor: KANDASAMY PACHAMUTHU
IPC: C07F9/24
Filed: 2020-03-19
Abstract: Among other things, the present disclosure provides technologies for oligonucleotide preparation, particularly chirally controlled oligonucleotide preparation, which technologies provide greatly improved crude purity and yield, and significantly reduce manufacturing costs.
Patent AU-2020265675-A1 (AU)
Title: Chambered handle for a medical device
Inventor: NGUYEN MAN MINH
IPC: A61B1/267
Filed: 2020-04-30
Abstract: A handle of an endoscope may comprise a body portion that defines a first chamber having a first feature configured to support at least a first component of a steering assembly, and a second chamber having a second feature configured to support at least one fluidic component (or fluidics component) or electronic component (or circuit board).
Patent AU-2020286281-A1 (AU)
Title: Evaporative air cooler with clip
Inventor: BARLETTANO SCOTT
IPC: F25D17/06
Filed: 2020-09-30
Abstract: Attorney Docket No. 64944.1715 
ABSTRACT 
An evaporative air cooler is described. The evaporative air cooler includes a housing 
defining an interior of the evaporative air cooler; a tank positioned adjacent to a top portion 
of the housing, wherein the tank is configured to receive, store, and release liquid; a mister in 
fluid communication with the tank, wherein the mister is configured to create a mist from the 
liquid; a filter structure with a filter, wherein the filter is configured to absorb the mist; a fan 
configured to draw the air into the interior, wherein the air is cooled by at least one of the 
mist and the filter, and wherein the fan directs the air through the filter structure and from the 
interior; and a clip coupled to the housing.  
-50-
Patent AU-2020287847-A1 (AU)
Title: Low temperature diversion in well completion operations using a langbeinite compound
Inventor: TODD BRADLEY L
IPC: C09K8/72
Filed: 2020-05-28
Abstract: Treatment fluids for use in fluid loss control, diversion, and plugging operations and methods of use are disclosed. The treatment fluids contain a degradable particular langbeinite material that temporarily creates a physical barrier to fluid flow before degrading over time with little to no effect on the environment. This degradable additive can be combined with other traditional downhole additives such as surfactants, viscosity ing agents, biocides and the like, allowing for a wide variety of applications in hydrocarbon reservoirs.
Patent AU-2020302861-A1 (AU)
Title: Baculovirus expression system
Inventor: CHEN HAIFENG
IPC: C12N15/34
Filed: 2020-06-25
Abstract: The present disclosure relates to a heterologous recombinant baculovirus (rBV) expression system for the production of foreign heterologous proteins in insect cells. This system comprises a recombinant baculovirus backbone within a genome with a deletion in the
Patent AU-2020321129-A1 (AU)
Title: Protected ports and catheters
Inventor: DOBRILOVIC NIKOLA
IPC: A61M39/10
Filed: 2020-07-16
Abstract: A protected port or catheter generally includes a cannula having at least one lumen and at least one access point in fluid communication with the at least one lumen. An access control mechanism controls fluid communication between the access point and the at least one lumen and is operable between closed and open positions. The access control mechanism may include a valve, a door, or a lockable cap. An actuator may be included for operating the access control mechanism between open and closed states. The actuator may be selectively operated by a control circuit. A power source may be provided to power the control circuit and actuator, if included.
Patent AU-2020323601-A1 (AU)
Title: Multivalent DNA antibody constructs and use thereof
Inventor: WEINER DAVID
IPC: A61K39/40
Filed: 2020-07-31
Abstract: Disclosed herein are compositions for generating a synthetic antibody or synthetic multivalent antibody in a subject. Also disclosed are methods for generating a synthetic antibody or synthetic multivalent antibody in a subject by administering a composition including one or more recombinant nucleic acid sequence that encodes a synthetic antibody or synthetic multivalent antibody to the subject. The disclosure also provides a compositions and methods of preventing and/or treating a Neisseria gonorrhoeae infection in a subject using said synthetic antibody or synthetic multivalent antibody.
Patent AU-2020323685-A1 (AU)
Title: Electrochemical cell and method of processing a gaseous stream containing hydrogen
Inventor: SCHMIDT JAN-JUSTUS
IPC: H01M8/0662
Filed: 2020-07-27
Abstract: An electrochemical cell, or stack thereof, wherein each cell of the stack comprises at least: a membrane electrode assembly (MEA), the MEA comprising at least: an anode, a cathode, and an an-ion exchange membrane therebetween, an inlet to the anodic half-cell for the introduction of hydrogen at a first pressure, and an outlet from the cathodic half-cell for the transfer of hydrogen at a second pressure, and means to provide a required power to the cell. In one embodiment, the purification and compression of hydrogen occurring by utilisation of the following reaction pathway: formula (A) and formula (B).
Patent AU-2020369008-A1 (AU)
Title: Watercraft and method for operating a watercraft
Inventor: FRANK MICHAEL
IPC: B63G8/00
Filed: 2020-09-29
Abstract: The invention relates to a watercraft (1), comprising at least one high-temperature superconducting coil (5, 15) and a cooling system for cooling the high-temperature superconducting coil (5, 15) to a cryogenic operating temperature, wherein the cooling system has a first cyrostat tank (10), which surrounds the high-temperature superconducting coil (5, 15) and is designed to hold a liquid phase (11) of a cryogenic coolant; wherein the watercraft (1) also has a load (6), which is designed to convert an operating medium in the form of a fuel and/or in the form of a material promoting combustion; wherein at least one first material component of the operating medium is formed by the cryogenic coolant; and wherein the first cryostat tank (10) is designed to hold a major part of the required total amount of the first material component of the operating medium for the operation of the load (6). The invention further relates to a method for operating a watercraft (1) of this type.
Patent AU-2020371662-A1 (AU)
Title: Adeno-associated virus (AAV) systems for treatment of progranulin associated neurodegenerative diseases or disorders
Inventor: LI JUAN
IPC: C12N15/86
Filed: 2020-10-22
Abstract: The disclosure provides, in part, optimally -modified progranulin (PGRN) cDNA and associated genetic elements for use in recombinant adeno-associated virus (rAAV)-based gene therapy for neurodegenerative disorders characterized by cognitive disruption, behavioral impairment, and deficient lysosomal storage, including familial frontotemporal dementia (FTD), frontotemporal lobar degeneration (FTLD), neuronal ceroid lipofuscinosis (NCL), or Alzheimer's disease (AD).
Patent AU-2020384311-A1 (AU)
Title: Secure artificial intelligence model training and registration system
Inventor: COENDERS GUIDO FRANCISCUS WILHELMUS
IPC: G06F21/16
Filed: 2020-11-13
Abstract: In general, this disclosure describes a system for securely training artificial intelligence (AI) models. The system may include communication circuitry for receiving from providers data sets, machine learning algorithms, and AI models. The data sets, machine learning algorithms, and AI models may be placed in a secure sandbox for access by a user. The user may securely train the AI models using the data sets in the secure sandbox. The secure sandbox may record AI model metadata associated with transactions involving the AI models and send the AI model metadata to a model registry. The model registry may attest to the lineage of the AI models.
Patent AU-2020405305-A1 (AU)
Title: Enhanced production of histidine, purine pathway metabolites, and plasmid DNA
Inventor: CHATZIVASILEIOU ALKIVIADIS ORFEFS
IPC: C12N15/52
Filed: 2020-12-16
Abstract: Aspects of the disclosure relate to biosynthesis of histidine in host cells. For example, host cells may comprise: a promoter; a ribosome binding site (RBS); and a nucleic acid comprising:
Patent AU-2020410383-A1 (AU)
Title: Improved wound care device
Inventor: KUMAR RAJESKHARAN ANAND
IPC: A61L15/46
Filed: 2020-12-16
Abstract: An antimicrobial amphiphilic hydrogel composition for use in haemostasis of a wound comprising: a first cross-linkable amphiphilic component, the first amphiphilic component, in its chemically cross-linked state, being a lyotropic liquid crystal and having an ordered nanostructure of hydrophobic and hydrophilic domains, the hydrogel comprising an antimicrobial agent covalently attached to the hydrophilic and/or hydrophobic domains.